ranatensin
SMILES | None |
InChIKey | AUOCWSNQHWTPIJ-UHFFFAOYSA-N |
Sequence | XVPQWAVGHFM |
Chemical properties
Hydrogen bond acceptors | None |
Hydrogen bond donors | None |
Rotatable bonds | None |
Molecular weight (Da) |
Drug properties
Molecular type | Peptide |
Physiological/Surrogate | Surrogate |
Approved drug | No |
Database connections
Bioactivities
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
BB2 | GRPR | Rat | Bombesin | A | pKi | 8.7 | 8.7 | 8.7 | Guide to Pharmacology |
BB1 | NMBR | Rat | Bombesin | A | pKi | 7.89 | 7.89 | 7.89 | Guide to Pharmacology |
BB3 | BRS3 | Human | Bombesin | A | pKi | 5.16 | 5.16 | 5.16 | PDSP Ki database |
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
BB1 | NMBR | Human | Bombesin | A | pIC50 | 8.35 | 8.59 | 8.83 | Guide to Pharmacology |
BB2 | GRPR | Human | Bombesin | A | pIC50 | 8.5 | 8.57 | 8.65 | Guide to Pharmacology |
BB2 | GRPR | Rat | Bombesin | A | pIC50 | 8.97 | 8.97 | 8.97 | Guide to Pharmacology |